The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 250 movers: Zoopla helps keep market marginally in the black

Fri, 08th Jan 2016 15:11

(ShareCast News) - The FTSE 250 remained in the black by mid-afternoon, but only just with the market up 0.27 points (0.00%) to 16,792.49.Zoopla Property Group surged nearly 7% after Berenberg issued an analysis of the media sector and reiterated its 'buy' rating for the property classifieds website as well as its target price of 300p.The investment bank said the online classified model is extremely attractive, especially when it comes to property. "At a critical mass, of which Zoopla has reached, there is a certain dependency from househunters and therefore a necessity for agents to be members." While On The Market has recently entered the scene, Berenberg didn't believe it differentiate enough from Zoopla it and won't last long-term, saying the disruption from the new competitor is an overreaction. "That said, OTM should still be considered a disruptor to what is a solid structural growth and margin development story."Vectura Group wasn't too far behind after it announced it had made a big step forward in the development of two of its products on Friday, VR315 and VR506, with the completion of a US clinical trial and the disclosure of its US development partner.The firm described VR315 as a generic, inhaled combination therapy of fluticasone and salmeterol, delivered to asthma and chronic obstructive pulmonary disease sufferers using a proprietary dry powder inhaler and Vectura's formulation technology. It also confirmed that its partner in developing the VR315 programme, as well as the VR506 product, was Roxane Laboratories - a subsidiary of Boehringer Ingelheime based in Connecticut.Just Eat also rose as investors digested a broker note from Jefferies that upgraded the company's price target from 515p to 550p and reiterated its 'buy' rating.It said that it isn't entirely sure if the website statistics have been priced in yet, but an increase of the commission it takes on takeaway orders to 14% certainly isn't. "Our recent review of JE's TR network suggests that TR's new to the UK network are now being charged a 14% commission rate. JE last upped the UK rate from 11% to 12% in January 2014, we conclude two things. The UK rate steps up to 14% not 13% and that this happens in 2016."As some uncertainty remained about what would happen next in China, one of the world's biggest commodities consumers, miners and oil companies continued to lead the fallers by the end of the week.Chinese markets appeared to be in a less fidgety mood, given Beijing had suspended its new circuit-breaker rule which closed the markets twice this week. The Shanghai Composite Index finished up 1.97% at 3,186.41, a slight recovery from the 7% dive it took during the 30-minute trading day on Thursday. However oil prices were still sitting around $33 a barrel, driven down after Iran has banned imports from Saudi Arabia as the rift between the two nations escalated earlier this week. It came as Iran reportedly accused Saudi Arabia of intentionally launching an airstrike on its embassy in Yemeni capital Sanaa.These international events all had an impact on seven of the 10 biggest fallers. Tullow Oil also had its target price lowered by JP Morgan from 310p to 295p. FTSE 250 - RisersZoopla Property Group (WI) (ZPLA) 240.40p 6.84%Vectura Group (VEC) 188.50p 5.84%Elementis (ELM) 217.50p 4.92%Just Eat (JE.) 474.20p 3.65%Marston's (MARS) 164.40p 3.53%Auto Trader Group (AUTO) 440.30p 3.24%Card Factory (CARD) 351.40p 2.78%Betfair Group (BET) 3,977.00p 2.76%BBA Aviation (BBA) 178.60p 2.70%Poundland Group (PLND) 172.00p 2.50%FTSE 250 - FallersTullow Oil (TLW) 141.30p -5.80%Evraz (EVR) 63.70p -5.77%Vedanta Resources (VED) 227.10p -5.22%Jimmy Choo (CHOO) 121.10p -4.12%Wood Group (John) (WG.) 560.00p -3.53%Petrofac Ltd. (PFC) 715.50p -3.51%Ophir Energy (OPHR) 85.05p -3.46%Debenhams (DEB) 65.50p -3.25%Cairn Energy (CNE) 137.00p -3.18%Enterprise Inns (ETI) 104.50p -3.15%
More News
19 Mar 2021 09:46

BROKER RATINGS: Barclays and Goldman Sachs downgrade Hammerson

BROKER RATINGS: Barclays and Goldman Sachs downgrade Hammerson

Read more
18 Mar 2021 10:36

Vectura shares rise on swing to profit, GBP115 million special payout

Vectura shares rise on swing to profit, GBP115 million special payout

Read more
18 Mar 2021 07:43

Royalty income, litigation win see Vectura beat expectations

(Sharecast News) - Vectura reported a 6.9% improvement in its total revenue on Thursday, to £190.6m, driven by development services and a surge in income from royalties.

Read more
11 Mar 2021 16:13

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
5 Mar 2021 12:29

Vectura delays results because of KPMG staff shortage

(Sharecast News) - Vectura delayed the publication of its annual results after KPMG asked for more time to audit the accounts because of a staff shortage caused by Covid-19.

Read more
2 Mar 2021 16:01

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
22 Jan 2021 09:32

LONDON BROKER RATINGS SUMMARY: Deutsche Bank Ups British Land, Landsec

LONDON BROKER RATINGS SUMMARY: Deutsche Bank Ups British Land, Landsec

Read more
12 Jan 2021 10:13

Vectura Forecasts 2020 Earnings To Top Board Expectations

Vectura Forecasts 2020 Earnings To Top Board Expectations

Read more
12 Jan 2021 08:16

Vectura reports 'strong' operational performance in 2020

(Sharecast News) - Inhaled medicines-focussed pharmaceutical company Vectura Group updated the market on its trading on Tuesday, saying it expected revenue and adjusted EBITDA for 2020 to be ahead of board expectations, following the fourth quarter approval of VR315 (US), or generic 'Advair', alongside Hikma.

Read more
30 Dec 2020 19:10

UK EXECUTIVE CHANGE SUMMARY: Nutrition Firm Director Joins Tate & Lyle

UK EXECUTIVE CHANGE SUMMARY: Nutrition Firm Director Joins Tate & Lyle

Read more
29 Dec 2020 12:04

Vectura Says Glaxo Will Not Appeal Award In Ellipta Litigation

Vectura Says Glaxo Will Not Appeal Award In Ellipta Litigation

Read more
29 Dec 2020 10:04

Glaxo not seeking re-hearing in Ellipta litigation, says Vectura

(Sharecast News) - Vectura said on Tuesday that GlaxoSmithKline has not sought to petition the US Court of Appeals for a re-hearing in the companies' ongoing litigation over GSK's Ellipta inhalers.

Read more
18 Dec 2020 17:08

LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal

LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal

Read more
18 Dec 2020 12:08

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

Read more
18 Dec 2020 10:45

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.